| 注册
首页|期刊导航|河北医学|术后化疗联合 DC-CIK 生物治疗胃癌的疗效观察

术后化疗联合 DC-CIK 生物治疗胃癌的疗效观察

任爱军

河北医学Issue(6):972-974,975,4.
河北医学Issue(6):972-974,975,4.DOI:10.3969/j.issn.1006-6233.2014.06.032

术后化疗联合 DC-CIK 生物治疗胃癌的疗效观察

Observation on Efficacy of Postoperative Chemotherapy Combined with DC-CIK Biotherapy in Treating Stomach Cancer

任爱军1

作者信息

  • 1. 山东省禹城市人民医院肿瘤科,山东 禹城 251200
  • 折叠

摘要

Abstract

Objective:To observe the clinical effect of postoperative chemotherapy combined with DC-CIK biotherapy in treating patients with stomach cancer , and make comparative analysis on clinical function of biotherapy .Method:58 cases with stomach cancer treated in our hospital from January 2010 to October 2013 were selected and divided into two groups randomly , the control group and the observation group .Two groups received operation treatment .The control group received single chemotherapy after operation , and the observation group received DC-CIK biotherapy based on the control group .The clinical efficacy of two groups was compared .Result: The clinical efficacy of the observation group was better than that of the control group, but the difference had no statistical significance (P﹥0.05).The life quality score of the observation group was evidently higher than that of the control group , and the adverse reactions were less than that of the control group, P ﹤0.05, which had statistical significance .Conclusion: Applying DC-CIK biotherapy based on conventional postoperative chemotherapy to patients with stomach cancer can ’ t evidently improve the clinical efficacy , but it can effectively reduce the adverse reactions and evidently improve the life quality of patients, which has ideal clinical efficacy .

关键词

胃癌/化疗/DC-CIK/生物治疗

Key words

Stomach cancer/Chemotherapy/DC-CIK/Biotherapy

引用本文复制引用

任爱军..术后化疗联合 DC-CIK 生物治疗胃癌的疗效观察[J].河北医学,2014,(6):972-974,975,4.

河北医学

OACSTPCD

1006-6233

访问量0
|
下载量0
段落导航相关论文